Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

When your child is diagnosed with nasal polyps, there are several effective ways to treat the disease and reduce ...

When analyzing nasal polyps scores, researchers observed a ... Similar to above, the likelihood for at least one oral corticosteroid course went down with mepolizumab vs. placebo in both surgery ...

Learn the essential facts about fungal sinus infections, from recognizing early warning signs to understanding treatment ...

Standard care for CRSwNP consists of corticosteroids in the nose ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron have said that CRSwNP has been helping to ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to chronic rhinosinusitis.

PARIS, France I April 15, 2025 I Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for ...

Xhance is an innovative drug-device therapy for chronic rhinosinusitis (CRS), with or without nasal polyps. Utilizing its proprietary Exhalation Delivery System, it delivers a corticosteroid ...

Xhance is an innovative drug-device therapy for chronic rhinosinusitis (CRS), with or without nasal polyps. Utilizing its proprietary Exhalation Delivery System, it delivers a corticosteroid directly ...